250 related articles for article (PubMed ID: 22825349)
1. Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.
Antoon JW; Bratton MR; Guillot LM; Wadsworth S; Salvo VA; Burow ME
Cancer Biol Ther; 2012 Sep; 13(11):1026-33. PubMed ID: 22825349
[TBL] [Abstract][Full Text] [Related]
2. Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells.
Song X; Wei Z; Shaikh ZA
Toxicol Appl Pharmacol; 2015 Aug; 287(1):26-34. PubMed ID: 26006730
[TBL] [Abstract][Full Text] [Related]
3. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1.
Frigo DE; Basu A; Nierth-Simpson EN; Weldon CB; Dugan CM; Elliott S; Collins-Burow BM; Salvo VA; Zhu Y; Melnik LI; Lopez GN; Kushner PJ; Curiel TJ; Rowan BG; McLachlan JA; Burow ME
Mol Endocrinol; 2006 May; 20(5):971-83. PubMed ID: 16410316
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase.
Antoon JW; Bratton MR; Guillot LM; Wadsworth S; Salvo VA; Elliott S; McLachlan JA; Burow ME
Am J Cancer Res; 2012; 2(4):446-58. PubMed ID: 22860234
[TBL] [Abstract][Full Text] [Related]
5. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenicity of MCF-7 human breast cancer cells lacking the p38α mitogen-activated protein kinase.
Mendoza RA; Moody EE; Enriquez MI; Mejia SM; Thordarson G
J Endocrinol; 2011 Jan; 208(1):11-9. PubMed ID: 20974639
[TBL] [Abstract][Full Text] [Related]
7. Virus-induced p38 MAPK activation facilitates viral infection.
Cheng Y; Sun F; Wang L; Gao M; Xie Y; Sun Y; Liu H; Yuan Y; Yi W; Huang Z; Yan H; Peng K; Wu Y; Cao Z
Theranostics; 2020; 10(26):12223-12240. PubMed ID: 33204339
[No Abstract] [Full Text] [Related]
8. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
[TBL] [Abstract][Full Text] [Related]
9. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
10. IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway.
Meng F; Yamagiwa Y; Taffetani S; Han J; Patel T
Am J Physiol Cell Physiol; 2005 Oct; 289(4):C971-81. PubMed ID: 15917303
[TBL] [Abstract][Full Text] [Related]
11. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.
Anbalagan M; Carrier L; Glodowski S; Hangauer D; Shan B; Rowan BG
Breast Cancer Res Treat; 2012 Apr; 132(2):391-409. PubMed ID: 21509526
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.
Antoon JW; Nitzchke AM; Martin EC; Rhodes LV; Nam S; Wadsworth S; Salvo VA; Elliott S; Collins-Burow B; Nephew KP; Burow ME
Int J Oncol; 2013 Apr; 42(4):1139-50. PubMed ID: 23403951
[TBL] [Abstract][Full Text] [Related]
13. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.
Liu H; Pedram A; Kim JK
Cardiovasc Res; 2011 Jan; 89(1):119-28. PubMed ID: 20724307
[TBL] [Abstract][Full Text] [Related]
15. Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells.
Zhang XT; Ding L; Kang LG; Wang ZY
Oncol Rep; 2012 Jun; 27(6):2057-65. PubMed ID: 22426783
[TBL] [Abstract][Full Text] [Related]
16. Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.
Herynk MH; Beyer AR; Cui Y; Weiss H; Anderson E; Green TP; Fuqua SA
Mol Cancer Ther; 2006 Dec; 5(12):3023-31. PubMed ID: 17172405
[TBL] [Abstract][Full Text] [Related]
17. LY2228820 dimesylate, a selective inhibitor of p38 mitogen-activated protein kinase, reduces angiogenic endothelial cord formation in vitro and in vivo.
Tate CM; Blosser W; Wyss L; Evans G; Xue Q; Pan Y; Stancato L
J Biol Chem; 2013 Mar; 288(9):6743-53. PubMed ID: 23335506
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase p38alpha and retinal ischemic preconditioning.
Dreixler JC; Barone FC; Shaikh AR; Du E; Roth S
Exp Eye Res; 2009 Nov; 89(5):782-90. PubMed ID: 19631642
[TBL] [Abstract][Full Text] [Related]
19. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
Liu H; Qiu J; Li N; Chen T; Cao X
J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
[TBL] [Abstract][Full Text] [Related]
20. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.
Catalano S; Mauro L; Marsico S; Giordano C; Rizza P; Rago V; Montanaro D; Maggiolini M; Panno ML; Andó S
J Biol Chem; 2004 May; 279(19):19908-15. PubMed ID: 14985328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
